Article
The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure.
Cardiology - 1 Jan 2009
Chen Guoli, Zhou Xiaoyang, Pathak Anand, Dorn Gerald W, Kranias Evangelia G
Abstract excerpt
OBJECTIVES: A human protein phosphatase inhibitor-1 polymorphism, G147D (c.440G>A, p.147G>D), has been previously demonstrated to blunt the contractile responses of cardiomyocytes to beta-adrenergic agonists. The present study sought to examine whether the G147D inhibitor-1 polymorphism may be associated with specific clinical characteristics of heart failure carriers. METHODS: Clinical information of 963 heart...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
